Lutetium-177 PNT6555 precisely targets FAP-expressing tumours with beta radiation
Radiotherapeutics

Lutetium-177 PNT6555: A Breakthrough in FAP-Targeted Radiopharmaceutical Therapy

Lutetium-177 PNT6555, a FAP-targeted radiopharmaceutical, combines precision therapy with beta radiation for tumour-specific treatment.

Lutetium-177 PNT6555: A Breakthrough in FAP-Targeted Radiopharmaceutical Therapy Read Post »

, , ,